Redirecting to original paper in 30 seconds...

Click below to go immediately or wait for automatic redirect

arxiv_ai 92% Match Research Paper Computational chemists,Drug discovery scientists,AI researchers in chemistry,Materials scientists 1 week ago

Uncertainty-Aware Multi-Objective Reinforcement Learning-Guided Diffusion Models for 3D De Novo Molecular Design

generative-ai › diffusion
📄 Abstract

Abstract: Designing de novo 3D molecules with desirable properties remains a fundamental challenge in drug discovery and molecular engineering. While diffusion models have demonstrated remarkable capabilities in generating high-quality 3D molecular structures, they often struggle to effectively control complex multi-objective constraints critical for real-world applications. In this study, we propose an uncertainty-aware Reinforcement Learning (RL) framework to guide the optimization of 3D molecular diffusion models toward multiple property objectives while enhancing the overall quality of the generated molecules. Our method leverages surrogate models with predictive uncertainty estimation to dynamically shape reward functions, facilitating balance across multiple optimization objectives. We comprehensively evaluate our framework across three benchmark datasets and multiple diffusion model architectures, consistently outperforming baselines for molecular quality and property optimization. Additionally, Molecular Dynamics (MD) simulations and ADMET profiling of top generated candidates indicate promising drug-like behavior and binding stability, comparable to known Epidermal Growth Factor Receptor (EGFR) inhibitors. Our results demonstrate the strong potential of RL-guided generative diffusion models for advancing automated molecular design.
Authors (4)
Lianghong Chen
Dongkyu Eugene Kim
Mike Domaratzki
Pingzhao Hu
Submitted
October 24, 2025
arXiv Category
cs.LG
arXiv PDF

Key Contributions

This paper proposes an uncertainty-aware Reinforcement Learning (RL) framework to guide 3D molecular diffusion models for multi-objective optimization. By leveraging surrogate models with predictive uncertainty, it dynamically shapes reward functions to balance multiple property objectives while improving generated molecule quality, outperforming baselines in molecular design.

Business Value

Accelerates the drug discovery and materials science pipelines by enabling the rapid design of novel molecules with specific, complex properties, potentially reducing R&D costs and time.